StockMacro
Menu

Oramed Pharmaceuticals

ORMP on XNAS, Oramed Pharmaceuticals Inc.

Measures activity, not value. Not investment advice.

Shares sold short (30 Oct 2026)

1.3M

-7.4% vs the report before

Short interest, % of shares outstanding

3.1%

43.5M shares outstanding (11 Nov 2026)

Days to cover

11.3

short interest / daily volume

Short sale volume share (20 Nov 2026)

36%

1-year median 43%

Sharp changes

23

short interest spike

Window
1.3M shares sold short on 30 Oct 2026, 3.1% of shares outstanding, 11.3 days to cover

FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.

See the numbers
30 Oct 2026: 1.3M shares sold short, 11.3 days to cover
15 Oct 2026: 1.5M shares sold short, 10.4 days to cover
30 Sep 2026: 1.4M shares sold short, 7.3 days to cover
15 Sep 2026: 1.3M shares sold short, 7.4 days to cover
31 Aug 2026: 1.2M shares sold short, 4.3 days to cover
14 Aug 2026: 1.0M shares sold short, 5.8 days to cover
31 Jul 2026: 835K shares sold short, 5.7 days to cover
15 Jul 2026: 765K shares sold short, 2.5 days to cover
30 Jun 2026: 878K shares sold short, 1.2 days to cover
15 Jun 2026: 570K shares sold short, 3.0 days to cover
29 May 2026: 659K shares sold short, 3.1 days to cover
15 May 2026: 635K shares sold short, 3.4 days to cover
30 Apr 2026: 651K shares sold short, 4.5 days to cover
15 Apr 2026: 577K shares sold short, 5.9 days to cover
31 Mar 2026: 563K shares sold short, 5.5 days to cover
13 Mar 2026: 542K shares sold short, 3.6 days to cover
27 Feb 2026: 556K shares sold short, 3.6 days to cover
13 Feb 2026: 540K shares sold short, 3.8 days to cover
30 Jan 2026: 645K shares sold short, 2.6 days to cover
15 Jan 2026: 409K shares sold short, 1.0 days to cover
31 Dec 2025: 424K shares sold short, 3.4 days to cover
15 Dec 2025: 315K shares sold short, 1.6 days to cover
28 Nov 2025: 357K shares sold short, 1.0 days to cover
14 Nov 2025: 245K shares sold short, 1.6 days to cover
31 Oct 2025: 242K shares sold short, 2.1 days to cover
15 Oct 2025: 209K shares sold short, 1.8 days to cover
30 Sep 2025: 280K shares sold short, 2.3 days to cover
15 Sep 2025: 224K shares sold short, 2.0 days to cover
29 Aug 2025: 348K shares sold short, 4.2 days to cover
15 Aug 2025: 364K shares sold short, 5.7 days to cover
31 Jul 2025: 404K shares sold short, 5.2 days to cover
15 Jul 2025: 404K shares sold short, 6.9 days to cover
30 Jun 2025: 419K shares sold short, 5.8 days to cover
13 Jun 2025: 475K shares sold short, 5.2 days to cover
30 May 2025: 489K shares sold short, 5.8 days to cover
15 May 2025: 591K shares sold short, 12.8 days to cover
30 Apr 2025: 655K shares sold short, 13.7 days to cover
15 Apr 2025: 709K shares sold short, 7.1 days to cover
31 Mar 2025: 651K shares sold short, 14.9 days to cover
14 Mar 2025: 665K shares sold short, 3.2 days to cover
28 Feb 2025: 616K shares sold short, 3.1 days to cover
14 Feb 2025: 576K shares sold short, 1.0 days to cover
31 Jan 2025: 231K shares sold short, 1.9 days to cover
15 Jan 2025: 248K shares sold short, 2.5 days to cover
31 Dec 2024: 242K shares sold short, 1.2 days to cover
13 Dec 2024: 291K shares sold short, 1.1 days to cover
29 Nov 2024: 300K shares sold short, 2.4 days to cover
15 Nov 2024: 314K shares sold short, 2.7 days to cover
31 Oct 2024: 300K shares sold short, 4.5 days to cover
15 Oct 2024: 298K shares sold short, 3.6 days to cover
30 Sep 2024: 340K shares sold short, 3.9 days to cover
13 Sep 2024: 354K shares sold short, 3.5 days to cover
30 Aug 2024: 363K shares sold short, 3.0 days to cover
15 Aug 2024: 237K shares sold short, 2.2 days to cover
31 Jul 2024: 278K shares sold short, 3.5 days to cover
15 Jul 2024: 335K shares sold short, 3.9 days to cover
28 Jun 2024: 529K shares sold short, 2.0 days to cover
14 Jun 2024: 468K shares sold short, 3.0 days to cover
31 May 2024: 287K shares sold short, 2.6 days to cover
15 May 2024: 305K shares sold short, 4.0 days to cover

What the numbers say

  • 1.3M shares sold short on 30 Oct 2026, 3.1% of shares outstanding, 11.3 days to cover; -7.4% on the report before (published by FINRA on 10 Nov 2026).

Every measure from this source

Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.

Days to cover. 11.3 days in the report of 30 Oct 2026, 1.6 a year earlier.
Short interest, % of shares outstanding. 3.1% in the report of 30 Oct 2026, 0.6% a year earlier.
Daily short sale volume share on off-exchange venues. 36% of the off-exchange volume on 20 Nov 2026 was a short sale; its median of the last 12 months 43%. This is a daily flow, not short interest.

Sharp changes

23 in all loaded history, strongest first

Oramed Pharmaceuticals had 2.5M shares sold short in the 14 May 2021 report, 12× the same report last year.

Short interest spike, became public on 26 May 2021

Same report last year: 210K; its normal report is 257K.

See the evidence
This period
2.5M (the 14 May 2021 report)
Normal report (median of 24 earlier)
257K
Typical spread (median absolute deviation)
73K
How far from its usual level
+20.8
Same report last year
210K
History used
1,232 days
2020-05-15: 210K2020-05-29: 229K2020-06-15: 257K2020-06-30: 215K2020-07-15: 195K2020-07-31: 232K2020-08-14: 230K2020-08-31: 257K2020-09-15: 193K2020-09-30: 176K2020-10-15: 174K2020-10-30: 221K2020-11-13: 218K2020-11-30: 279K2020-12-15: 1.1M2020-12-31: 946K2021-01-15: 808K2021-01-29: 1.2M2021-02-12: 1.8M2021-02-26: 1.7M2021-03-15: 1.8M2021-03-31: 2.2M2021-04-15: 2.2M2021-04-30: 2.3M2021-05-14: 2.5M
the 14 May 2021 report24 earlier reportsnormal: 257K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Oramed Pharmaceuticals had 2.5M shares sold short in the 28 May 2021 report, 11× the same report last year.

Short interest spike, became public on 10 Jun 2021

Same report last year: 229K; its normal report is 268K.

See the evidence
This period
2.5M (the 28 May 2021 report)
Normal report (median of 24 earlier)
268K
Typical spread (median absolute deviation)
93K
How far from its usual level
+16.1
Same report last year
229K
History used
1,246 days
2020-05-29: 229K2020-06-15: 257K2020-06-30: 215K2020-07-15: 195K2020-07-31: 232K2020-08-14: 230K2020-08-31: 257K2020-09-15: 193K2020-09-30: 176K2020-10-15: 174K2020-10-30: 221K2020-11-13: 218K2020-11-30: 279K2020-12-15: 1.1M2020-12-31: 946K2021-01-15: 808K2021-01-29: 1.2M2021-02-12: 1.8M2021-02-26: 1.7M2021-03-15: 1.8M2021-03-31: 2.2M2021-04-15: 2.2M2021-04-30: 2.3M2021-05-14: 2.5M2021-05-28: 2.5M
the 28 May 2021 report24 earlier reportsnormal: 268K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Oramed Pharmaceuticals had 2.3M shares sold short in the 30 Apr 2021 report, 15× the same report last year.

Short interest spike, became public on 12 May 2021

Same report last year: 160K; its normal report is 245K.

See the evidence
This period
2.3M (the 30 Apr 2021 report)
Normal report (median of 24 earlier)
245K
Typical spread (median absolute deviation)
60K
How far from its usual level
+23.5
Same report last year
160K
History used
1,218 days
2020-04-30: 160K2020-05-15: 210K2020-05-29: 229K2020-06-15: 257K2020-06-30: 215K2020-07-15: 195K2020-07-31: 232K2020-08-14: 230K2020-08-31: 257K2020-09-15: 193K2020-09-30: 176K2020-10-15: 174K2020-10-30: 221K2020-11-13: 218K2020-11-30: 279K2020-12-15: 1.1M2020-12-31: 946K2021-01-15: 808K2021-01-29: 1.2M2021-02-12: 1.8M2021-02-26: 1.7M2021-03-15: 1.8M2021-03-31: 2.2M2021-04-15: 2.2M2021-04-30: 2.3M
the 30 Apr 2021 report24 earlier reportsnormal: 245K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Oramed Pharmaceuticals had 2.2M shares sold short in the 15 Apr 2021 report, 14× the same report last year.

Short interest spike, became public on 27 Apr 2021

Same report last year: 164K; its normal report is 231K.

See the evidence
This period
2.2M (the 15 Apr 2021 report)
Normal report (median of 24 earlier)
231K
Typical spread (median absolute deviation)
51K
How far from its usual level
+26.3
Same report last year
164K
History used
1,203 days
2020-04-15: 164K2020-04-30: 160K2020-05-15: 210K2020-05-29: 229K2020-06-15: 257K2020-06-30: 215K2020-07-15: 195K2020-07-31: 232K2020-08-14: 230K2020-08-31: 257K2020-09-15: 193K2020-09-30: 176K2020-10-15: 174K2020-10-30: 221K2020-11-13: 218K2020-11-30: 279K2020-12-15: 1.1M2020-12-31: 946K2021-01-15: 808K2021-01-29: 1.2M2021-02-12: 1.8M2021-02-26: 1.7M2021-03-15: 1.8M2021-03-31: 2.2M2021-04-15: 2.2M
the 15 Apr 2021 report24 earlier reportsnormal: 231K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Oramed Pharmaceuticals had 2.2M shares sold short in the 31 Mar 2021 report, 9.7× the same report last year.

Short interest spike, became public on 13 Apr 2021

Same report last year: 229K; its normal report is 229K.

See the evidence
This period
2.2M (the 31 Mar 2021 report)
Normal report (median of 24 earlier)
229K
Typical spread (median absolute deviation)
43K
How far from its usual level
+31.4
Same report last year
229K
History used
1,188 days
2020-03-31: 229K2020-04-15: 164K2020-04-30: 160K2020-05-15: 210K2020-05-29: 229K2020-06-15: 257K2020-06-30: 215K2020-07-15: 195K2020-07-31: 232K2020-08-14: 230K2020-08-31: 257K2020-09-15: 193K2020-09-30: 176K2020-10-15: 174K2020-10-30: 221K2020-11-13: 218K2020-11-30: 279K2020-12-15: 1.1M2020-12-31: 946K2021-01-15: 808K2021-01-29: 1.2M2021-02-12: 1.8M2021-02-26: 1.7M2021-03-15: 1.8M2021-03-31: 2.2M
the 31 Mar 2021 report24 earlier reportsnormal: 229K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Oramed Pharmaceuticals had 1.8M shares sold short in the 12 Feb 2021 report, 3.3× the same report last year.

Short interest spike, became public on 25 Feb 2021

Same report last year: 550K; its normal report is 229K.

See the evidence
This period
1.8M (the 12 Feb 2021 report)
Normal report (median of 24 earlier)
229K
Typical spread (median absolute deviation)
37K
How far from its usual level
+28.8
Same report last year
550K
History used
1,141 days
2020-02-14: 550K2020-02-28: 597K2020-03-13: 190K2020-03-31: 229K2020-04-15: 164K2020-04-30: 160K2020-05-15: 210K2020-05-29: 229K2020-06-15: 257K2020-06-30: 215K2020-07-15: 195K2020-07-31: 232K2020-08-14: 230K2020-08-31: 257K2020-09-15: 193K2020-09-30: 176K2020-10-15: 174K2020-10-30: 221K2020-11-13: 218K2020-11-30: 279K2020-12-15: 1.1M2020-12-31: 946K2021-01-15: 808K2021-01-29: 1.2M2021-02-12: 1.8M
the 12 Feb 2021 report24 earlier reportsnormal: 229K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.